Alzheimer's disease

Another Alzheimer's Disease Failure

Another Alzheimer's Disease Failure

The Motley Fool

Lilly halts Alzheimer's drug trial due to liver problems

Lilly halts Alzheimer's drug trial due to liver problems

Reuters

Forest Announces U.S. Availability of New Once-Daily NAMENDA XR

Forest Announces U.S. Availability of New Once-Daily NAMENDA XR

Yahoo

Novartis Ramps Up Alzheimer’s Drug Pursuit as Rivals Fail

Novartis Ramps Up Alzheimer’s Drug Pursuit as Rivals Fail

Bloomberg

Failure Of Baxter's Trial Another Blow To Alzheimer's Treatment

Failure Of Baxter's Trial Another Blow To Alzheimer's Treatment

Forbes

NeuroPhage banks $6.4M for Alzheimer's drug development effort

NeuroPhage banks $6.4M for Alzheimer's drug development effort

Fierce Biotech

Biotech startup hustles new Alzheimer's program to the clinic

Biotech startup hustles new Alzheimer's program to the clinic

Fierce Biotech

Eli Lilly Sues J&J for Patents Rights in Alzheimer Drug Race

Eli Lilly Sues J&J for Patents Rights in Alzheimer Drug Race

Bloomberg

Lilly And Sanofi CEOs Take Two Very Different R&D Paths In Alzheimer's Disease

Lilly And Sanofi CEOs Take Two Very Different R&D Paths In Alzheimer's Disease

Forbes

Marking the Way for Alzheimer's Drugs

Marking the Way for Alzheimer's Drugs

Motley Fool